The review, authored by Ruiying Ma, U Suk Kim, Yousun Chung and Kihoon Han of Korea University College of Medicine and collaborators, draws together recent time-resolved studies of a mouse model carrying the CYFIP2 Arg87Cys mutation, a recurrent genetic variant found in children with West syndrome. The animals recapitulate the human trajectory with unusual fidelity: seizure-like events in the neonatal period, a prolonged seizure-free juvenile interval, spontaneous recurrent seizures beginning around postnatal week 14, and premature death. By applying transcriptomic, ultrastructural, proteomic and lipidomic analyses across four postnatal stages, the researchers have produced the first multi-omic portrait of seizure evolution in a West syndrome model, and the picture it paints is one of continuous, quietly destructive renovation.

The clinical backdrop makes the case compelling. More than 900 epilepsy genes have now been catalogued, the majority linked to developmental and epileptic encephalopathies, the most severe class of epilepsies. In West syndrome, up to 60 percent of children who survive infantile spasms go on to develop other seizure types, and roughly one quarter to one third eventually meet criteria for Lennox-Gastaut syndrome. Critically, in a recent multicenter cohort, two thirds of children who evolved to that syndrome passed through an interval of complete seizure freedom first. Similar gaps appear elsewhere in the genetic epilepsy landscape: 38 percent of adults with KCNQ2 encephalopathy have experienced seizure-free periods of at least two years followed by recurrence, and the so-called honeymoon period is a recognized stage of CDKL5 deficiency disorder.

The therapeutic implication, as the review notes, has been stated explicitly in the Lennox-Gastaut literature: if the neural network is being reorganized during the gap, then the gap is precisely when intervention is most likely to alter the disease trajectory. The obstacle is that the child looks improved, brain tissue is inaccessible, and no tool exists to determine whether a patient is progressing toward a worse syndrome or has genuinely stabilized. Even the electroencephalogram offers only partial reassurance, because slow spike-and-wave activity, the electrical signature of Lennox-Gastaut syndrome, can appear before or during the clinically quiet interval, suggesting the brain never actually stopped misfiring.

This is where the mouse model becomes invaluable, because only in animals can the hidden interval be dissected cell by cell. One of the most unexpected structural findings concerns excitatory synapses in the hippocampus, the brain’s memory hub and a common seat of seizure genesis. At the time spontaneous seizures emerge and again two weeks later, the number of excitatory synapses in region CA1 falls, while inhibitory synapse numbers are preserved. On its face, fewer excitatory synapses should mean a calmer network, which sits awkwardly with the onset of recurrent seizures. The electron microscope resolved the paradox, at least as a hypothesis: dendritic spines, the tiny protrusions that normally receive excitatory inputs, were markedly reduced, and the remaining excitatory synapses had relocated onto the dendritic shaft itself, with multiple presynaptic boutons frequently converging on individual shafts.

That relocation matters because spine architecture is not merely decorative. The narrow neck of a spine electrically and biochemically isolates each synapse from its neighbors, compartmentalizing signals. Shaft synapses bypass that barrier entirely. The authors propose, carefully and as a hypothesis awaiting functional testing, that fewer synapses moved to the shaft could allow more effective integration of convergent excitatory inputs, producing stronger synchronization of neuronal activity even as the synapse count drops. The structural remodeling was accompanied by asymmetric molecular shifts, with postsynaptic proteins such as Shank3, Homer1 and GluA2 decreased while presynaptic markers like Synaptotagmin-1 and Synapsin 1 increased, and by altered splicing of the neurexin genes Nrxn2 and Nrxn3, whose isoform choices are known to instruct synapse specification. Axonal hypermyelination completed the picture, echoing other epilepsy models in which maladaptive myelin is thought to speed seizure propagation through the brain.

Equally striking was the behavior of the glia, the brain’s support cells, which engaged in a discernible sequence rather than all at once. The number of Olig2-positive oligodendrocyte-lineage cells rose first, at postnatal week 7, during the seizure-free interval, and persisted thereafter. Microglia, the brain’s immune cells, followed at week 14, showing simplified, ameboid morphology, elevated CD68 phagocytic signal and increased proinflammatory cytokine transcripts. Reactive astrocytes appeared at weeks 14 and 28. Gene set enrichment analysis of the bulk transcriptome mirrored the same ordering. The sequence is broadly consistent with work in acquired epilepsy, where microglial activation has been shown to be required for subsequent reactive astrogliosis and epileptogenesis, but the mouse data place all three glial lineages on a single temporal framework within one disease model for the first time. The authors are careful to note that the widely spaced sampling points mean the ordering is suggested rather than established, and because CYFIP2 is expressed predominantly in neurons, the glial changes are almost certainly secondary responses to altered neuronal activity rather than direct effects of the variant.

The latest and arguably most ominous changes were metabolic. By week 28, electron microscopy revealed enlarged lipid droplets within astrocyte lysosomes, together with crystalline material never observed in wild-type animals, and astrocytic mitochondria that were smaller and lacked distinct cristae. Multiple independent datasets converged: single-nucleus transcriptomics identified an astrocyte subtype enriched for oxidative phosphorylation and fatty acid metabolism genes, the proteins APOD and PTGDS were prominently upregulated, and lipidomic profiling showed increased triacylglycerol, diacylglycerol and cholesteryl ester, the major lipid classes stored in lipid droplets. The findings fit an emerging framework in which hyperactive neurons offload excess fatty acids to astrocytes for oxidation, while lipid-laden reactive astrocytes in temporal lobe epilepsy show impaired glutamate uptake and drive disease progression. Whether the same feed-forward loop operates here remains unproven, since the lipid changes appeared only after weeks of seizures and could simply mark cumulative seizure burden rather than cause it.

Indeed, the review is as notable for what it admits it does not know as for what it reports. The deepest analyses, including electron microscopy and single-nucleus transcriptomics, were performed only at week 28, after seizures were established, while the critical transition between weeks 7 and 14 went unsampled. Higher-resolution assays were applied at fewer time points, a tradeoff the authors describe candidly: analytical depth was purchased at the expense of temporal coverage, leaving the clinically silent interval, the stage that matters most, the least well characterized. The only molecular data spanning the pre-onset period came from the bulk transcriptome, in which differentially expressed genes numbered just 20 and 41 at weeks 1 and 7 before exploding to 3,755 at week 14, hinting that molecular change simmered near the threshold of detection until seizures emerged. Electrophysiology was similarly sparse, with video-EEG recordings at a single time point in only three animals, meaning the interval is seizure-free by behavioral criteria alone and silent interictal activity cannot be excluded. A useful internal control, Cyfip2 haploinsufficient mice showing only 19 differentially expressed genes and no seizures, argues the knock-in phenotype reflects a toxic gain of function rather than simple gene dosage.

The downstream implications reach toward the clinic. The temporal data suggest that different interventions belong to different stages: allele-selective suppression of the mutant transcript, for instance with antisense oligonucleotides, would likely work best early, before glial engagement; anti-inflammatory or glia-targeted approaches would fit an intermediate stage; and metabolic or lipid-restoring strategies, such as liver-X receptor agonism, might apply later. None of this helps patients, however, unless the stage can be identified prospectively, and no validated staging biomarkers exist for these disorders. Candidate markers are accumulating, from the EEG detection of slow spike-and-wave activity before relapse, to plasma GFAP and neurofilament light chain, to the PTGDS and APOD proteins that emerged from the mouse work. The review’s central message is that the seizure-free interval should be reframed not as remission but as a remodeling phase, one that dense, onset-aligned sampling of the model, and parallel biomarker development in patients, could convert from a clinically silent enigma into a well-defined window for stage-specific therapy.

Subject of Research: Time-resolved multi-omic phenotyping of seizure evolution in the CYFIP2 Arg87Cys mouse model of West syndrome

Article Title: Time-resolved phenotyping of seizure evolution in developmental and epileptic encephalopathy: insights and gaps from the CYFIP2 Arg87Cys mouse model

Article References: Ma, R., Kim, U. S., Chung, Y., & Han, K. (2026). Time-resolved phenotyping of seizure evolution in developmental and epileptic encephalopathy: insights and gaps from the CYFIP2 Arg87Cys mouse model. Frontiers in Synaptic Neuroscience, 18, Article 1963161. https://doi.org/10.3389/fnsyn.2026.1963161

Image Credits: AI Generated

DOI: 10.3389/fnsyn.2026.1963161

Keywords: West syndrome, CYFIP2, developmental and epileptic encephalopathy, seizure-free interval, Lennox-Gastaut syndrome, synaptic remodeling, gliosis, astrocytes, lipid droplets, microglia, oligodendrocytes, biomarkers

Infantile epileptic spasms syndrome, historically known as West syndrome, is a developmental and epileptic encephalopathy that typically emerges in the first year of life. Its signature manifestation is the epileptic spasm: a sudden, brief contraction of the trunk and limb muscles that can resemble a startle reflex, colic, or reflux. Clusters of these spasms often occur on waking, and because they are so easily mistaken for benign infant behaviors, the condition is notorious for slipping past the first clinician who sees it. The electroencephalographic hallmark, hypsarrhythmia, is a chaotic, disorganized pattern of very high-voltage waves that reflects profound cerebral dysfunction. Treatment with adrenocorticotropic hormone, oral corticosteroids, or vigabatrin is time-sensitive, and international guidance emphasizes that prompt initiation of therapy substantially improves developmental outcomes.

The stakes are amplified in settings where pediatric neurologists are scarce. In Palestine, access to subspecialty neurology services is limited, which means frontline physicians, including general practitioners, family medicine specialists, and pediatricians working in district hospitals and clinics, effectively serve as the diagnostic gatekeepers. If they fail to recognize spasms, order an urgent electroencephalogram, and escalate the case, the window for effective treatment can close before the child ever reaches a specialist. This structural reality is precisely what motivated the research team, led by investigators at Al-Quds University and collaborating institutions including An-Najah National University and Palestine Polytechnic University, to measure how prepared the frontline actually is.

Between March and June 2026, the team administered a structured, self-administered questionnaire to pediatricians, general practitioners, family medicine specialists, and residents in pediatrics or family medicine practicing across the West Bank. The instrument was designed around the established knowledge, attitudes, and practices framework, a standard tool in health-services research for diagnosing gaps that can be targeted by training. Knowledge was assessed with twenty items scored from zero to twenty, attitudes with twelve Likert-scale items ranging from twelve to sixty, and clinical practices with ten scenario-based items scored from zero to twenty-eight. Knowledge was then categorized as poor at or below fifty percent, fair between fifty and seventy percent, and good above seventy percent, a threshold the authors treated as the adequacy benchmark for safe practice.

The headline numbers are sobering. Overall, 48.7 percent of participants demonstrated good knowledge, 53.0 percent held positive attitudes, and 52.5 percent exhibited good clinical practices. The mean knowledge score was 13.5 out of 20, equivalent to 67.4 percent, which fell statistically significantly below the 70 percent adequacy benchmark. In other words, the average physician in the sample sat just under the line that the investigators considered minimally acceptable, and nearly half of the cohort fell clearly below it. The authors report that the most pronounced deficits concerned the etiology and prognosis of the syndrome, domains that determine whether a clinician understands why urgent action matters and what the child’s future looks like without it.

The stratified analysis revealed a steep gradient across specialties. Pediatricians scored 15.8 on knowledge, compared with 11.6 for primary care physicians and 13.3 for residents, a difference that was highly significant. The same pattern held for attitudes, with mean scores of 44.5, 40.7, and 41.2 respectively, and for practices, where pediatricians averaged 20.4 against 15.9 for primary care physicians and 17.4 for residents. This hierarchy is clinically consequential because primary care physicians are often the first, and sometimes the only, medical professionals a worried parent consults when a baby begins exhibiting unusual movements. The group least equipped to recognize the syndrome is, in this system, positioned at the front door.

The statistical architecture of the study went beyond simple group comparisons. The team used independent samples t-tests and one-way analysis of variance to compare subgroups, Pearson correlations to probe relationships between the three domains, and multiple linear regression to identify independent predictors while controlling for confounders. The correlations were telling: knowledge tracked strongly with practices, with a correlation coefficient of 0.645, and moderately with attitudes at 0.380. This suggests that what doctors know about infantile spasms is tightly coupled to what they actually do when confronted with a suspected case, and that attitudinal readiness alone cannot compensate for missing factual knowledge. In the regression models, specialty group and male gender emerged as the strongest independent predictors of all three scores, indicating that the knowledge gap is not evenly distributed and that training interventions should be targeted rather than generic.

Perhaps the most actionable finding concerns perceived barriers. When asked what most impedes early diagnosis, 37.7 percent of respondents identified lack of provider awareness as the leading obstacle. That figure is striking because it comes from the physicians themselves: the frontline workforce recognizes that its own awareness is the bottleneck. Unlike resource constraints or referral bottlenecks, which require systemic investment, provider awareness is a problem that continuing medical education can, in principle, address directly. The authors conclude that targeted continuing medical education programs, particularly for primary care physicians and residents, have the potential to improve early recognition and management of the syndrome in Palestine.

The study’s design carries both strengths and limitations worth noting. The sample of 419 participants is large for a survey of this kind, and the scenario-based practice items move beyond self-report by asking clinicians to respond to realistic clinical vignettes. The instrument’s content validity was assessed using the scale-level content validity index, and the analysis included checks for multicollinearity using variance inflation factors. However, as a cross-sectional survey, it captures a snapshot rather than a trajectory, and self-administered questionnaires are inherently vulnerable to response bias. The authors also note that the findings apply to the West Bank and may not generalize to other health systems, although the pattern of specialty-dependent knowledge gaps echoes concerns raised in studies from other resource-limited settings.

For the global child-neurology community, the Palestinian data sharpen a broader message. Infantile epileptic spasms syndrome is among the most time-critical diagnoses in medicine, yet its presentation mimics ordinary infant behaviors, and its victims cannot describe their symptoms. Where pediatric neurologists are plentiful, the frontline still matters; where they are scarce, the frontline is everything. The Palestinian study suggests that a modest, well-aimed educational intervention, focused on the primary care physicians and residents who see these babies first, could shift outcomes for a condition in which the difference between prompt and delayed treatment is measured in a child’s lifelong cognitive trajectory. The research was approved by the Al-Quds University Research Ethics Committee and conducted in accordance with the Declaration of Helsinki, with informed consent from all participants, and it appears in the open-access literature so that clinicians and educators elsewhere can build on it.

Subject of Research: Physician knowledge, attitudes, and practices regarding infantile epileptic spasms syndrome in Palestine

Article Title: Infantile spasms in Palestine: knowledge, attitudes, and practices among pediatric and primary care physicians and residents

Article References: Alhaddar, M., Darawsheh, R., Shalalfa, N., Ewidat, S., Abu-Hanieh, D., Abdallah, N., Mohsen, M., Almahdi, A., Alhouseini, M., Nasser, A., Elbaou, B., Alwawi, A., & Zrineh, A. (2026). Infantile spasms in Palestine: knowledge, attitudes, and practices among pediatric and primary care physicians and residents. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07816-0

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07816-0

Keywords: infantile spasms, infantile epileptic spasms syndrome, West syndrome, pediatric epilepsy, primary care, Palestine, West Bank, knowledge attitudes practices, continuing medical education, neurodevelopmental disorders, EEG, diagnostic delay